Lurie Investment Fund

NanoInk is specialized in nanometer-scale manufacturing and applications development for the life science and semiconductor industries.

CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

Discera, a fabless analog semiconductor firm, manufactures and distributes silicon resonators to radio frequency and timing control markets.

Viamet discovers and develops small molecule inhibitors via an enzyme binding approach for the treatment of various diseases.

HandyLab is a business that provides the world with research into medical technology.

Aperion Biologics is a clinical-stage medical device company developing a technique to make animal-tissues usable for human applications.

Cernium Corporation, a software company based in Reston, Virginia, develops and delivers video analytics-enabled products.

CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

RenaMed Biologics engages in the development of therapies for the treatment of diseases associated with compromised kidney function.